Genetic Variations in Hairy Cell Leukemia with Brain Involvement: Case Report

被引:0
作者
Tessa Harland
Mahmoud Aldyab
Jiang Qian
Tipu Nazeer
Robert S. Heller
机构
[1] Albany Medical Center,Department of Neurosurgery
[2] Albany Medical Center,Department of Pathology
关键词
Hairy cell leukemia; Brain involvement; Case report;
D O I
10.1007/s42399-023-01535-8
中图分类号
学科分类号
摘要
Hairy cell leukemia (HCL) is an infrequent neoplasm of mature B cells with rare neurologic involvement. These patients typically present with symptoms related to splenomegaly or cytopenia with rare neurologic involvement. Most neurologic involvement is predominately related to infection secondary to associated pancytopenia rather than neoplasm. To date, there are only three published reports of brain parenchymal involvement with variable treatment response and limited information on genetic profile. A 64-year-old male presenting with several neurological complaints including 2 months of headache and frequent falls is found to have laboratory and bone marrow biopsy results consistent with HCL. Notably, genetic testing was negative for the BRAF V600E mutation seen in classic HCL. MRI head with and without contrast showed innumerable T1 hyperintense rim-enhancing lesions in the bilateral cerebral hemispheres primarily concentrated in the frontal lobes. Neurosurgical biopsy was requested to resolve the diagnostic question of infection versus neoplastic etiology of the brain lesions. Pathology results and flow cytometry confirmed diagnosis of HCL brain involvement. Herein, we describe a case of diffuse HCL involvement of the brain in the framework of genetic variations to aid the understanding of this rare neurologic manifestation of HCL.
引用
收藏
相关论文
共 42 条
[1]  
Morton LM(2006)Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001 Blood. 107 265-276
[2]  
Wang SS(2011)Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network Br J Cancer 105 1684-1692
[3]  
Devesa SS(2011)BRAF mutations in hairy-cell leukemia N Engl J Med 364 2305-2315
[4]  
Hartge P(2019)Hairy cell leukemia: 2020 update on diagnosis, risk stratification, and treatment Am J Hematol 94 1413-1422
[5]  
Weisenburger DD(1994)Hairy cell leukemia: a clinical review based on 725 cases of the Italian Cooperative Group (ICGHCL). Italian Cooperative Group for Hairy Cell Leukemia Leuk Lymphoma 13 307-316
[6]  
Linet MS(1984)Neurologic complications of hairy cell leukemia Arch Neurol 41 202-203
[7]  
Smith A(1986)Involvement of the nervous system in hairy-cell leukemia Arch Neurol 43 432-e188
[8]  
Howell D(2013)Rare case of hairy cell leukemia with brain parenchymal involvement: a diagnostic dilemma J Clin Oncol 31 e186-902
[9]  
Patmore R(2017)Multifocal brain involvement in a patient with hairy cell leukemia successfully treated with rituximab and cladribine Blood Adv 1 899-10
[10]  
Jack A(2014)High prevalence of MAP2K1 mutations in variant and IGHV4-34-expressing hairy-cell leukemias Nat Genet 46 8-1805